Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | The Medicines Co. | 0.23% | 84.22 | 20.1% | $621.39m | |
| AMRN | Amarin Corp. Plc | 4.92% | 24.12 | 1.7% | $270.04m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.79% | 31.00 | 14.1% | $182.41m | |
| ARQL | ArQule, Inc. | 0.38% | 20.07 | 0.6% | $144.81m | |
| SAGE | SAGE Therapeutics, Inc. | 0.39% | 72.87 | 8.6% | $138.32m | |
| BHC | Bausch Health Cos., Inc. | -2.79% | 31.00 | 0.0% | $131.64m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.53% | 114.16 | 16.9% | $95.13m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.35% | 147.88 | 2.3% | $90.60m | |
| GWPH | GW Pharmaceuticals Plc | 0.87% | 106.62 | 6.2% | $87.33m | |
| PRGO | Perrigo Co. Plc | -1.10% | 53.93 | 6.8% | $63.24m | |
| AXSM | Axsome Therapeutics, Inc. | -3.67% | 46.79 | 2.0% | $58.98m | |
| HZNP | Horizon Therapeutics Plc | 1.83% | 32.84 | 6.6% | $43.02m | |
| ICLR | ICON plc | -1.40% | 159.31 | 4.2% | $42.14m | |
| UTHR | United Therapeutics Corp. | -4.41% | 89.63 | 14.3% | $35.22m | |
| ENDP | Endo International Plc | -1.49% | 4.63 | 8.8% | $33.25m |
Company Profile
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.